Reckitt Benckiser Completes Adams Purchase

Reckitt Benckiser Group plc successfully completed its acquisition of Adams Respiratory Therapeutics Inc. through a cash tender offer followed by a short- form merger of its indirect wholly owned subsidiary, Twickenham Inc., with and into Adams. As a result of this acquisition, Adams becomes an indirect wholly owned subsidiary of Reckitt Benckiser. At the effective time of the merger, all outstanding shares of Adams common stock not validly tendered and accepted for payment in the tender offer were converted into the right to receive $60.00 per share in cash (the same price paid in the tender offer), without interest and subject to applicable withholding of taxes. American Stock Transfer & Trust Company, acting as the paying agent for the merger, will mail to the remaining former shareholders of Adams materials necessary to exchange their former Adams shares for such payment. As a result of the merger, Adams shares will be delisted and cease to trade on the NASDAQ Global Select Market.